Author:
Baxa Jan,Matouskova Tana,Krakorova Gabriela,Schmidt Bernhard,Flohr Thomas,Sedlmair Martin,Bejcek Jiri,Ferda Jiri
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine
Reference30 articles.
1. Cappuzzo F, Ciuleanu T, Stelmakh L et al (2010) Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study. Lancet Oncol 11:521–529
2. Al-Farsi A, Ellis PM (2014) Treatment paradigms for patients with metastatic non-small cell lung cancer, squamous lung cancer: first, second, and third-line. Front Oncol 27:157
3. Shepherd FA, Rodrigues Pereira J, Ciuleanu T et al (2005) Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353:123–132
4. Genestreti G, Grossi F, Genova C et al (2014) Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview. Future Oncol 10:2081–2096
5. Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247